KEYU series Feces Analyzers, urine analyzers and related reagents have been approved and certified by the Brazilian National Health Regulatory Agency (ANVISA).

On January 26, 1999, Brazil established the National Health Surveillance Agency (ANVISA). ANVISA regulates and supervises the production, importation, distribution and use of medical products, pharmaceuticals, food, cosmetics, medical devices and other related products in Brazil.

ANVISA's mission is to protect and promote the health of the Brazilian public by ensuring that products on the market meet safety, quality and efficacy standards. 

Brazil is the largest healthcare market in Latin America. As one of the BRIC economies, Brazil represents a huge opportunity for market growth. It is a good opportunity for KEYU to explore the Latin American market.

Brazil is a strictly regulated medical device market, and only ANVISA-registered medical devices are able to  prove their legitimacy and quality, thus gaining a competitive advantage in the market and increasing consumer trust.

In conclusion, the Brazilian ANVISA registration for medical devices is essential to ensure the legitimacy, safety and quality of medical devices.

ANVISA's certification is a full affirmation of the quality of KEYU series products, and lays a good foundation  for KEYU to continue to develop the global market and serve more people.